Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_assertion type Assertion NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_head.
- NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_assertion description "[Activation to a large extent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and mutations in the p53 gene are involved in lung cancer therapeutic resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_provenance.
- NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_assertion evidence source_evidence_literature NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_provenance.
- NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_assertion SIO_000772 20811722 NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_provenance.
- NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_assertion wasDerivedFrom befree-2016 NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_provenance.
- NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_assertion wasGeneratedBy ECO_0000203 NP836638.RAtoF_h1PrrHgA8eK1c-W-3M8PVE1IvPrd07XABxhGBvo130_provenance.